Pharmaceutical Testing and Analytical Services Market Size, Share, Trends, Growth, Consumption, Revenue, Company Analysis and Forecast 2021-2027

Published Date : Nov 2020 | No. of Pages : 200 Pages | Category : Healthcare

According to Vision Research Reports, the global pharmaceutical testing and analytical services market size surpassed at US$ 3.6 Bn in 2019 and to reach US$ 10.4 billion by 2027 with a CAGR of 10% from 2021 to 2027.

Rise in the number of clinical trials is a major factor boosting the market. The number of clinical trials being conducted globally has been increasing significantly for the past few years. Rise in the number of clinical trials is being driven by a surge in the demand for innovative solutions in the healthcare industry, owing to technological advancements in the industry. For instance, in 2018, 293,341 active clinical trials were carried out for the design and development of new products.

Pharmaceutical testing and quality assurance are important stages in the pharmaceutical industry. Testing and analysis are carried out as people’s lives depend on the quality and quantity measure of a given medicine. Bioanalytical testing, method development & validation, raw material testing, stability testing, and microbial testing are commonly employed tests adopted in pharmaceutical and medical devices industries. The expansion of the global pharmaceutical testing and analytical services market can be ascribed to rise in the number of clinical trials and increase in R&D spending.

North America dominated the global pharmaceutical testing and analytical services market in 2019. This trend is anticipated to continue during the forecast period. Highly structured healthcare industry and increase in incidence of disease are likely to boost the market in North America. Furthermore, the presence of major market players who are focused on design and development of new treatment options for the treatment of major chronic diseases is likely to further drive the market in North America. Asia Pacific is likely to be a highly lucrative region of the global pharmaceutical testing and analytical services market. It is projected to expand at a rapid pace during the forecast period.

Rise in Number of Clinical Trials and Increase in R&D Spending to Drive Global Market

The increase in the number of clinical trials is projected to boost the pharmaceutical testing and analytical services market. Rising prevalence of cancer is a key factor driving the number of clinical trials being conducted. Furthermore, it is estimated that the number of clinical trials in oncology increased from over 2,400 in 2007 to over 7,000 in 2017. Increase in R&D spending and focus of biopharmaceutical companies on boosting revenues has propelled the pharmaceutical testing and analytical services market.

Inorganic growth is a key strategy adopted by major players operating in the pharmaceutical testing and analytical services market in order to consolidate their position in the market. On January 3, 2020, Charles River Laboratories International, Inc. acquired HemaCare, a leading company specializing in the production of human derived cellular products for the cell therapy market. These factors are estimated to propel the pharmaceutical testing and analytical services market during the forecast period.

Bioanalytical Testing Segment to Dominate Global Market

Based on service type, the global pharmaceutical testing and analytical services market has been divided into bioanalytical testing, method development & validation, raw material testing, stability testing, microbial testing, and others. The bioanalytical testing segment has been further segmented into cell-based assays, virology testing, and others. The method development & validation segment has been sub-segmented into extractables & leachables method development and validation, stability-indicating method validation, process impurity method development & validation, and others. The raw material testing segment has been split into heavy metal testing, complete compendial testing, and others. The stability testing segment has been further classified into drug substance stability testing, formulation evaluation stability testing, and others. The microbial testing segment has been further divided into microbial limit testing, sterility testing, endotoxin testing, and others. The bioanalytical testing segment dominated the global pharmaceutical testing and analytical services market in 2019. This trend is projected to continue during the forecast period.

The increase in use of cell-based assay, virology, and other tests in drug development is likely boost the bioanalytical testing segment during the forecast period. Cell-based assays have been a key component in streamlining the drug development process, helping drugs to be introduced in the market in a rapid and efficient manner.

The method development & validation segment was followed by the bioanalytical testing segment, in terms of market share, in 2019.

Pharmaceutical & Biopharmaceutical Companies to Offer Lucrative Opportunities

In terms of end user, the global pharmaceutical testing and analytical services market has been split into medical device companies, pharmaceutical & biopharmaceutical companies, and others. The pharmaceutical & biopharmaceutical companies segment accounted for a prominent share of the global pharmaceutical testing and analytical services market in 2019. The expansion of the segment can be attributed to a surge in focus of biopharmaceutical companies on expansion, shifting fixed costs to variable costs, and incorporation of technological advances in their research process, which is highly cost intensive. These factors are fueling the outsourcing of the research & development process, thereby boosting the segment.

North America to Dominate Global Pharmaceutical Testing and Analytical Services Market

The global pharmaceutical testing and analytical services market has been divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global pharmaceutical testing and analytical services market in 2019. It was followed by Europe. The U.S. dominated the market in North America, owing to the presence of major market players, significant healthcare expenditure, and increase in research activities across the region. Robust expansion of the market in the region can be attributed to increase in the number of clinical trials and a rise in the demand for biosimilars owing to patent expiry, which fuels the demand for rapid conduction of trials and regulatory approvals. This, in turn, fuels the demand for analytical testing from pharmaceutical manufacturers and consequently boosts the market.

The pharmaceutical testing and analytical services market in Asia Pacific is anticipated to expand at a rapid rate from 2020 to 2030.

Competition Landscape

The global pharmaceutical testing and analytical services market is fragmented in terms of number of players. Key players operating in the global market include Eurofins Scientific, Laboratory Corporation of America Holdings, CHARLES RIVER LABORATORIES INTERNATIONAL, INC., SGS S.A., Intertek Group plc, RD Laboratories, Inc., WuXi AppTec Co., Ltd., DYNALABS LLC (Infinity Laboratories), and ARL Bio Pharma.

Market Segmentation

By Service Type

  • Bioanalytical Testing
    • Cell-based Assays
    • Virology Testing
    • Others
  • Method Development & Validation
    • Extractables & Leachables Method Development and Validation
    • Stability-indicating Method Validation
    • Process Impurity Method Development & Validation
    • Others
  • Raw Material Testing
    • Heavy Metal Testing
    • Complete Compendial Testing
    • Others
  • Stability Testing
    • Drug Substance Stability Testing
    • Formulation Evaluation Stability Testing
    • Others
  • Microbial Testing
    • Microbial Limit Testing
    • Sterility Testing
    • Endotoxin Testing
    • Others
  • Others

By End User

    • Medical Device Companies
    • Pharmaceutical & Biopharmaceutical Companies
    • Others

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific          
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Scope of the Report

VRR’s report on the global pharmaceutical testing and analytical services market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators for the market during the forecast period from 2020 to 2027. The report provides revenue of the global pharmaceutical testing and analytical services market for the period 2018–2027, considering 2020 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) of the global pharmaceutical testing and analytical services market from 2020 to 2030.

The report is prepared after an extensive research. Primary research involves bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Extensive secondary research involved reaching out to key players’ product literature, annual reports, press releases, and relevant documents to understand the pharmaceutical testing and analytical services market.

Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the pharmaceutical testing and analytical services market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global pharmaceutical testing and analytical services market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global pharmaceutical testing and analytical services market.

The report delves into the competition landscape of the global pharmaceutical testing and analytical services market. Key players operating in the global pharmaceutical testing and analytical services market are identified and each one of these is profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global pharmaceutical testing and analytical services market profiled in this report.

Key Questions Answered in Pharmaceutical Testing and Analytical Services Market Report

  1. What is the sales/revenue generated by pharmaceutical testing and analytical services across all regions during the forecast period?
  2. What are the opportunities in the global pharmaceutical testing and analytical services market?
  3. What are the major drivers, restraints, opportunities, and threats in the market?
  4. Which regional market is set to expand at the fastest CAGR during the forecast period?
  5. Which service type segment is expected to generate the highest revenue globally in 2030? Which segment is projected to expand at the highest CAGR during the forecast period?
  6. What are the market positions of different companies operating in the global market?

Research Objectives and Research Approach

The comprehensive report on the global pharmaceutical testing and analytical services market begins with an overview, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global pharmaceutical testing and analytical services market in terms of service type, end user, and region. Key segments under each criteria are studied at length, and the market share for each of these at the end of 2030 has also been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global pharmaceutical testing and analytical services market.

Table of Contents

1. Preface

    1.1. Report Scope and Market Segmentation

    1.2. Research Highlights

2. Assumptions and Research Methodology

    2.1. Assumptions and Acronyms Used

    2.2. Research Methodology

3. Executive Summary

4. Market Overview

    4.1. Introduction

    4.2. Key Industry Developments

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunity

    4.4. Global Pharmaceutical Testing and Analytical Services Market Forecast

    4.5. Global Pharmaceutical Testing and Analytical Services Market Outlook

5. Market Outlook

    5.1. Key Industrial Events (Licensing Partnership/Merger & Acquisition)

    5.2. Clinical Trials Analysis

    5.3. Covid-19 Impact Analysis

6. Global Pharmaceutical Testing and Analytical Services Market Analysis, by Service Type

    6.1. Introduction

    6.2. Global Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Service Type

    6.3. Global Pharmaceutical Testing and Analytical Services Market Forecast, by Service Type

        6.3.1. Bioanalytical Testing

            6.3.1.1. Cell-Based Assays

            6.3.1.2. Virology Testing

            6.3.1.3. Others

        6.3.2. Method Development & Validation

            6.3.2.1. Extractables & Leachables Method Development & Validation

            6.3.2.2. Stability-indicating Method Validation

            6.3.2.3. Process Impurity Method Development & Validation

            6.3.2.4. Others

        6.3.3. Raw Material Testing

            6.3.3.1. Heavy Metal Testing

            6.3.3.2. Complete Compendial Testing

            6.3.3.3. Others

        6.3.4. Stability Testing

            6.3.4.1. Drug Substance Stability Testing

            6.3.4.2. Formulation Evaluation Stability Testing

            6.3.4.3. Others

        6.3.5. Microbial Testing

            6.3.5.1. Microbial Limit Testing

            6.3.5.2. Sterility Testing

            6.3.5.3. Endotoxin Testing

            6.3.5.4. Others

        6.3.6. Others

    6.4. Global Pharmaceutical Testing and Analytical Services Market Analysis, by Service Type

7. Global Pharmaceutical Testing and Analytical Services Market Analysis, by End-user

    7.1. Introduction

    7.2. Global Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by End-user

    7.3. Global Pharmaceutical Testing and Analytical Services Market Forecast, by End-user

        7.3.1. Medical Device Companies

        7.3.2. Pharmaceutical & Biopharmaceutical Companies

        7.3.3. Others

    7.4. Global Pharmaceutical Testing and Analytical Services Market Analysis, by End-user

8. Global Pharmaceutical Testing and Analytical Services Market Analysis, by Region

    8.1. Global Pharmaceutical Testing and Analytical Services Market Scenario, by Region

    8.2. Global Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Region

    8.3. Global Pharmaceutical Testing and Analytical Services Market Forecast, by Region

        8.3.1. North America

        8.3.2. Europe

        8.3.3. Asia Pacific

        8.3.4. Latin America

        8.3.5. Middle East & Africa

9. North America Pharmaceutical Testing and Analytical Services Market Analysis

    9.1. North America Pharmaceutical Testing and Analytical Services Market Overview

    9.2. North America Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Country

    9.3. North America Pharmaceutical Testing and Analytical Services Market Forecast, by Country

        9.3.1. U.S.

        9.3.2. Canada

    9.4. North America Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Service Type

    9.5. North America Pharmaceutical Testing and Analytical Services Market Forecast, by Service Type

        9.5.1. Bioanalytical Testing

            9.5.1.1. Cell-Based Assays

            9.5.1.2. Virology Testing

            9.5.1.3. Others

        9.5.2. Method Development & Validation

            9.5.2.1. Extractables & Leachables Method Development & Validation

            9.5.2.2. Stability-indicating Method Validation

            9.5.2.3. Process Impurity Method Development & Validation

            9.5.2.4. Others

        9.5.3. Raw Material Testing

            9.5.3.1. Heavy Metal Testing

            9.5.3.2. Complete Compendial Testing

            9.5.3.3. Others

        9.5.4. Stability Testing

            9.5.4.1. Drug Substance Stability Testing

            9.5.4.2. Formulation Evaluation Stability Testing

            9.5.4.3. Others

        9.5.5. Microbial Testing

            9.5.5.1. Microbial Limit Testing

            9.5.5.2. Sterility Testing

            9.5.5.3. Endotoxin Testing

            9.5.5.4. Others

        9.5.6. Others

    9.6. North America Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by End-user

    9.7. North America Pharmaceutical Testing and Analytical Services Market Forecast, by End-user

        9.7.1. Medical Devices Companies

        9.7.2. Pharmaceutical & Biopharmaceutical Companies

        9.7.3. Others

10. Europe Pharmaceutical Testing and Analytical Services Market Analysis

    10.1. Europe Pharmaceutical Testing and Analytical Services Market Overview

    10.2. Europe Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Country/Sub-region

    10.3. Europe Pharmaceutical Testing and Analytical Services Market Forecast, by Country/Sub-region

        10.3.1. Germany

        10.3.2. France

        10.3.3. U.K.

        10.3.4. Italy

        10.3.5. Spain

        10.3.6. Rest of Europe

    10.4. Europe Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Service Type

    10.5. Europe Pharmaceutical Testing and Analytical Services Market Forecast, by Service Type

        10.5.1. Bioanalytical Testing

            10.5.1.1. Cell-Based Assays

            10.5.1.2. Virology Testing

            10.5.1.3. Others

        10.5.2. Method Development & Validation

            10.5.2.1. Extractables & Leachables Method Development & Validation

            10.5.2.2. Stability-indicating Method Validation

            10.5.2.3. Process Impurity Method Development & Validation

            10.5.2.4. Others

        10.5.3. Raw Material Testing

            10.5.3.1. Heavy Metal Testing

            10.5.3.2. Complete Compendial Testing

            10.5.3.3. Others

        10.5.4. Stability Testing

            10.5.4.1. Drug Substance Stability Testing

            10.5.4.2. Formulation Evaluation Stability Testing

            10.5.4.3. Others

        10.5.5. Microbial Testing

            10.5.5.1. Microbial Limit Testing

            10.5.5.2. Sterility Testing

            10.5.5.3. Endotoxin Testing

            10.5.5.4. Others

        10.5.6. Others

    10.6. Europe Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by End-user

    10.7. Europe Pharmaceutical Testing and Analytical Services Market Forecast, by End-user

        10.7.1. Medical Devices Companies

        10.7.2. Pharmaceutical & Biopharmaceutical Companies

        10.7.3. Others

11. Asia Pacific Pharmaceutical Testing and Analytical Services Market Analysis

    11.1. Asia Pacific Pharmaceutical Testing and Analytical Services Market Overview

    11.2. Asia Pacific Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Country/Sub-region

    11.3. Asia Pacific Pharmaceutical Testing and Analytical Services Market Forecast, by Country/Sub-region

        11.3.1. Japan

        11.3.2. China

        11.3.3. India

        11.3.4. Australia & New Zealand

        11.3.5. Rest of Asia Pacific

    11.4. Asia Pacific Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Service Type

    11.5. Asia Pacific Pharmaceutical Testing and Analytical Services Market Forecast, by Service Type

        11.5.1. Bioanalytical Testing

            11.5.1.1. Cell-Based Assays

            11.5.1.2. Virology Testing

            11.5.1.3. Others

        11.5.2. Method Development & Validation

            11.5.2.1. Extractables & Leachables Method Development & Validation

            11.5.2.2. Stability-indicating Method Validation

            11.5.2.3. Process Impurity Method Development & Validation

            11.5.2.4. Others

        11.5.3. Raw Material Testing

            11.5.3.1. Heavy Metal Testing

            11.5.3.2. Complete Compendial Testing

            11.5.3.3. Others

        11.5.4. Stability Testing

            11.5.4.1. Drug Substance Stability Testing

            11.5.4.2. Formulation Evaluation Stability Testing

            11.5.4.3. Others

        11.5.5. Microbial Testing

            11.5.5.1. Microbial Limit Testing

            11.5.5.2. Sterility Testing

            11.5.5.3. Endotoxin Testing

            11.5.5.4. Others

        11.5.6. Others

    11.6. Asia Pacific Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by End-user

    11.7. Asia Pacific Pharmaceutical Testing and Analytical Services Market Forecast, by End-user

        11.7.1. Medical Devices Companies

        11.7.2. Pharmaceutical & Biopharmaceutical Companies

        11.7.3. Others

12. Latin America Pharmaceutical Testing and Analytical Services Market Analysis

    12.1. Latin America Pharmaceutical Testing and Analytical Services Market Overview

    12.2. Latin America Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Country/Sub-region

    12.3. Latin America Pharmaceutical Testing and Analytical Services Market Forecast, by Country/Sub-region

        12.3.1. Brazil

        12.3.2. Mexico

        12.3.3. Rest of Latin America

    12.4. Latin America Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Service Type

    12.5. Latin America Pharmaceutical Testing and Analytical Services Market Forecast, by Service Type

        12.5.1. Bioanalytical Testing

            12.5.1.1. Cell-Based Assays

            12.5.1.2. Virology Testing

            12.5.1.3. Others

        12.5.2. Method Development & Validation

            12.5.2.1. Extractables & Leachables Method Development & Validation

            12.5.2.2. Stability-indicating Method Validation

            12.5.2.3. Process Impurity Method Development & Validation

            12.5.2.4. Others

        12.5.3. Raw Material Testing

            12.5.3.1. Heavy Metal Testing

            12.5.3.2. Complete Compendial Testing

            12.5.3.3. Others

        12.5.4. Stability Testing

            12.5.4.1. Drug Substance Stability Testing

            12.5.4.2. Formulation Evaluation Stability Testing

            12.5.4.3. Others

        12.5.5. Microbial Testing

            12.5.5.1. Microbial Limit Testing

            12.5.5.2. Sterility Testing

            12.5.5.3. Endotoxin Testing

            12.5.5.4. Others

        12.5.6. Others

    12.6. Latin America Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by End-user

    12.7. Latin America Pharmaceutical Testing and Analytical Services Market Forecast, by End-user

        12.7.1. Medical Devices Companies

        12.7.2. Pharmaceutical & Biopharmaceutical Companies

        12.7.3. Others

13. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Analysis

    13.1. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Overview

    13.2. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Country/Sub-region

    13.3. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Forecast, by Country/Sub-region

        13.3.1. GCC Countries

        13.3.2. South Africa

        13.3.3. Rest of Middle East & Africa

    13.4. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Service Type

    13.5. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Forecast, by Service Type

        13.5.1. Bioanalytical Testing

            13.5.1.1. Cell-Based Assays

            13.5.1.2. Virology Testing

            13.5.1.3. Others

        13.5.2. Method Development & Validation

            13.5.2.1. Extractables & Leachables Method Development & Validation

            13.5.2.2. Stability-indicating Method Validation

            13.5.2.3. Process Impurity Method Development & Validation

            13.5.2.4. Others

        13.5.3. Raw Material Testing

            13.5.3.1. Heavy Metal Testing

            13.5.3.2. Complete Compendial Testing

            13.5.3.3. Others

        13.5.4. Stability Testing

            13.5.4.1. Drug Substance Stability Testing

            13.5.4.2. Formulation Evaluation Stability Testing

            13.5.4.3. Others

        13.5.5. Microbial Testing

            13.5.5.1. Microbial Limit Testing

            13.5.5.2. Sterility Testing

            13.5.5.3. Endotoxin Testing

            13.5.5.4. Others

        13.5.6. Others

    13.6. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by End-user

    13.7. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Forecast, by End-user

        13.7.1. Medical Devices Companies

        13.7.2. Pharmaceutical & Biopharmaceutical Companies

        13.7.3. Others

14. Competitive Landscape

    14.1. Competition Matrix

    14.2. Global Pharmaceutical Testing and Analytical Services Market Share Analysis, by Company

    14.3. Company Profile

        14.3.1. Eurofins Scientific  

            14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.1.2. Financial Overview

            14.3.1.3. Product Portfolio

            14.3.1.4. SWOT Analysis

            14.3.1.5. Strategic Overview

        14.3.2. Laboratory Corporation of America Holdings

            14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.2.2. Financial Overview

            14.3.2.3. Product Portfolio

            14.3.2.4. SWOT Analysis

            14.3.2.5. Strategic Overview

        14.3.3. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

            14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.3.2. Financial Overview

            14.3.3.3. Product Portfolio

            14.3.3.4. SWOT Analysis

            14.3.3.5. Strategic Overview

        14.3.4. SGS S.A

            14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.4.2. Product Portfolio

            14.3.4.3. SWOT Analysis

            14.3.4.4. Strategic Overview

        14.3.5. Intertek Group plc

            14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.5.2. Financial Overview

            14.3.5.3. Product Portfolio

            14.3.5.4. SWOT Analysis

            14.3.5.5. Strategic Overview

        14.3.6. RD Laboratories, Inc

            14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.6.2. Financial Overview

            14.3.6.3. Product Portfolio

            14.3.6.4. SWOT Analysis

            14.3.6.5. Strategic Overview

        14.3.7. WuXi AppTec Co., Ltd.

            14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.7.2. Financial Overview

            14.3.7.3. Product Portfolio

            14.3.7.4. SWOT Analysis

            14.3.7.5. Strategic Overview

        14.3.8. DYNALABS LLC (Infinity Laboratories)

            14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.8.2. Financial Overview

            14.3.8.3. Product Portfolio

            14.3.8.4. SWOT Analysis

            14.3.8.5. Strategic Overview

        14.3.9. ARL Bio Pharma

            14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.9.2. Financial Overview

            14.3.9.3. Product Portfolio

            14.3.9.4. SWOT Analysis

            14.3.9.5. Strategic Overview


Featured Research Reports

  • Featured Research Reports

    Retinal Disorders Treatment Market (By Indication: Macular Degeneration, Diabetic Retinopathy, Diabetic Macular Edema, and Others; By Therapeutic Class; By Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030

    Read more...
  • Featured Research Reports

    Dystrophic Epidermolysis Bullosa Treatment Market (By Treatment Type: Antibiotics, Corticosteroids, Opioid Analgesics, Anticonvulsant, Others; By Disease Type: DDEB and RDEB; By Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030

    Read more...
  • Featured Research Reports

    Bromelain Market (By Application: Food & Beverages, Healthcare & Pharmaceuticals, Cosmetics, and Other Industries; By Source: Stem and Fruit) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030

    Read more...
  • Featured Research Reports

    Chronic Idiopathic Constipation Treatment Market (By Drug Class: Serotonin-4 [5-Ht4] Receptor Agonist, Guanylate Cyclase-C Agonist, Laxatives, Stimulants, Others; By Route of Administration: Oral and Rectal; By Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030

    Read more...
  • Featured Research Reports

    Hemoglobin Feed Market (By Source: Bovine, Swine, Poultry, Shark, Synthetic, Others; By Application: Industrial and Commercial) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030

    Read more...